LCK and neoplasm: On the other side, it has been recently shown that Lck is aberrantly expressed in T-acute lymphoblastic leukemia (T-ALL) patients displaying resistance to glucocorticoid (GC) treatment, and specific Lck inhibition or LCK gene silencing strikingly increases GC-induced cell death of tumor cells [59].